Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Endo Pharmaceuticals Inc. v. Actavis, Inc., No. 13-1658 (Fed. Cir. Mar. 31, 2014)

Vacated & Remanded
Injunction License / Exhaustion
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 13-1658
Also Docketed
No. 13-1662 (consolidated; same document)
Decided
March 31, 2014
Judge
Moore, J.
Document
Precedential Opinion
Length
27 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Endo Pharmaceuticals, Inc. (Endo) appeals from the district court’s order denying its motions for a preliminary injunction to prevent Roxane Laboratories, Inc. (Roxane), Actavis Inc., and Actavis South Atlantic LLC (Actavis) from marketing and selling their respective generic drug products during the pendency of this litigation. B ecause ENDO PHARMACEUTICALS INC. v. ACTAVIS, INC.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error